Archive for October 2017
Evaluate the effect of intrinsic and extrinsic factors on regorafenib (REG) exposure
Ploeger B., Cleton A., Keunecke A., Bruix J., Meinhardt G. Population pharmacokinetics (popPK) to evaluate the effect of intrinsic and extrinsic factors on regorafenib (REG) exposure in REG studies including patients with hepatocellular carcinoma (HCC). The American Society of Clinical Oncology – Gastrointestinal Cancers Symposium, 2017.
Read MoreFrequency-Domain Response Analysis for Quantitative Systems Pharmacology Models
Schulthess P., Post T.M., Yates J., Graaf P.H.v.d. Frequency-Domain Response Analysis for Quantitative Systems Pharmacology Models. CPT Pharmacometrics Syst Pharmacol: 111–123, 2018. [Link to publication]
Read More